Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil
Introduction Parenteral antimony-based compounds are still the standard of care for cutaneous leishmaniasis (CL) treatment in many countries, despite their high toxicity. Previous studies showed that oral azithromycin...
| Main Authors: | Toledo Junior, Antonio, Daher, André Bastos, Amaral, Thaís Alves, Carvalho, Sílvio Fernando Guimarães, Romero, Gustavo Adolfo Sierra, Rabello, Ana |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2017
|
| Subjects: | |
| Online Access: |
http://repositorio.unb.br/handle/10482/29128 https://dx.doi.org/10.1590/0037-8682-0266-2014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
